Phenotyping of tumors into ‘hot’, ‘cold’ or ‘altered’ based on infiltration of CD3+ and CD8+ T-cells at tumor center and margin (Immunoscore)7, PD-1/PD-L1 expression, and tumor mutation burden are important determinants of response to immunotherapy in solid cancers8,9. The gene discussed is CD8A; the disease is neoplasm.